Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
AOD-9604
Max Weight Loss12.3%
Studies3
Participants78
StatusAvailable

AOD-9604

Human Growth Hormone Fragment 176-191

AOD-9604 is a modified fragment of human growth hormone (HGH) comprising amino acids 176-191 from the C-terminus. Developed by Metabolic Pharmaceuticals, this peptide specifically targets fat loss without the growth-promoting effects of full HGH. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation), making it a targeted approach for body composition improvement and weight management.

Complete Dosing Guide

Quick Reference

250-500
Typical Dose
Daily
Frequency
Approximately
Half-Life
SubQ
Route

Administration Method

Subcutaneous injection, typically daily

Step-by-Step Dosing Protocol

Days 1-7
300-600 mcg
Initial fat mobilization
Take before bed for optimal growth hormone release
Days 8-21
300-600 mcg
Peak fat burning phase
Monitor body composition changes
Days 22-42
300-600 mcg
Sustained fat loss
Continue for optimal body recomposition
Days 43+
Cycle or maintain
Long-term protocol
Consider cycling or maintenance dose

Dosing Guidelines

Research Protocol

Clinical protocols typically begin with 250 mcg daily for the first week to assess tolerance, followed by escalation to 500 mcg daily for weeks 2-4. Optimal efficacy is generally achieved at 1 mg daily, administered as a single subcutaneous injection. Some protocols utilize twice-daily dosing of 500 mcg (morning and evening) for enhanced fat oxidation. Treatment cycles typically range from 8-12 weeks, with some extended protocols lasting up to 6 months. The peptide should be administered on an empty stomach, preferably 30 minutes before exercise for enhanced lipolytic effects.

Simple Explanation

Most people start with a small dose (250 mcg) for the first week to make sure they tolerate it well. Then they increase to 500 mcg daily for a few weeks. The best results usually come from 1mg per day, given as one shot. Some people split this into two smaller shots (morning and evening) which can work even better. Treatment usually lasts 2-3 months, though some people use it for up to 6 months. For best results, inject it on an empty stomach about 30 minutes before working out.

Mixing & Injection

Technical Instructions

Subcutaneous injection using insulin syringes (29-31 gauge, 0.5-1.0 mL capacity) into fatty tissue areas including abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy. The lyophilized powder must be reconstituted with bacteriostatic water (1-2 mL depending on desired concentration). Store reconstituted solution under refrigeration and use within 30 days. Administer at consistent times daily, preferably before meals or exercise when growth hormone levels are naturally elevated.

Step-by-Step Guide

Subcutaneous injection using insulin syringes (29-31 gauge, 0.5-1.0 mL capacity) into fatty tissue areas including abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy. The lyophilized powder must be reconstituted with bacteriostatic water (1-2 mL depending on desired concentration). Store reconstituted solution under refrigeration and use within 30 days. Administer at consistent times daily, preferably before meals or exercise when growth hormone levels are naturally elevated.

Clinical Administration Guidelines

Injection Protocol

  • Subcutaneous injection daily before bed
  • Rotate between abdomen, thigh, upper arm
  • Daily before bed for optimal effects
  • Can be taken with or without food

Monitoring Schedule

  • Weekly weight and body composition measurements
  • Monthly metabolic markers if applicable
  • Quarterly lipid panels
  • Regular vital signs monitoring

Dosage Calculator

Loading Calculator...

Medical Disclaimer

AOD-9604 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.